While the loss of ADAR1 or its editing activity indicates tumour sensitivity to ADAR1 depletion in a number of settings, direct evidence for the oncogenic role of ADAR1 through gain-of-function experiments remains elusive and worthy of future studies. The gene discussed is ADAR; the disease is neoplasm.